about
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydroca...
Read More
1.93
0.03
(1.58%)
3.1M
XNAS Volume
High volume today
XNAS 22 Sep, 2026 5:30 PM (EDT)
Board Meeting
The board meeting for Equillium Inc is scheduled for today, for the purpose of Stifel’s 2026 Virtual Immunology and Inflammation Forum
See details
Not Eligible
Expensive Valuation
Technically Neutral
Equillium Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..